Access Denied

Markets settle lower after hitting record peaks in intra-day; Sensex breaches 75,000-milestone

The BSE benchmark jumped 494.28 points or 0.67% to settle at a new closing peak of 74,742.50 on April 8. File. | Photo Credit: Reuters Benchmark equity indices ended marginally lower on April 9 amid profit-taking after the BSE Sensex breached the historic 75,000-mark for the first time ever in early trade and the Nifty...<p class="more-link-wrap"><a href="https://artifex.news/article68046486-ece/" class="more-link">Read More<span class="screen-reader-text"> “Markets settle lower after hitting record peaks in intra-day; Sensex breaches 75,000-milestone”</span> »</a></p>

NLCIL mines get five-star rating of Union Coal Ministry

The star rating policy of the Ministry of Coal is a transformative initiative aimed at enhancing the performance and sustainability of coal and lignite sector entities. File | Photo Credit: Photo credit: https://www.nlcindia.in Lignite and coal mines of NLC India Limited (NLCIL) have notched up top scores and five-star ratings for the year 2023-24 in...<p class="more-link-wrap"><a href="https://artifex.news/article70021819-ece/" class="more-link">Read More<span class="screen-reader-text"> “NLCIL mines get five-star rating of Union Coal Ministry”</span> »</a></p>

Rupee falls 5 paise to 88.21 against U.S. dollar in early trade

Foreign Institutional Investors bought equities worth ₹390.74 crore on a net basis on September 19, 2025, according to exchange data. File | Photo Credit: Reuters The rupee witnessed range-bound trading in morning deals on Monday (September 22, 2025) and depreciated 5 paise to 88.21 against the U.S. dollar, as the strength of the American currency in...<p class="more-link-wrap"><a href="https://artifex.news/article70079326-ece/" class="more-link">Read More<span class="screen-reader-text"> “Rupee falls 5 paise to 88.21 against U.S. dollar in early trade”</span> »</a></p>

Sun Pharma gets DCGI nod to make, market generic semaglutide injection in India for weight management

Image used for representation purpose only. | Photo Credit: Reuters Sun Pharmaceutical Industries Ltd said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct...<p class="more-link-wrap"><a href="https://artifex.news/article70541273-ece/" class="more-link">Read More<span class="screen-reader-text"> “Sun Pharma gets DCGI nod to make, market generic semaglutide injection in India for weight management”</span> »</a></p>

Access Denied

Access Denied You don’t have permission to access “http://www.ndtvprofit.com/markets/kalyani-steels-bf-utilities-settle-sebi-case-for-rs-4-12-crore-over-related-party-transaction-violations-11126734” on this server. Reference #18.6824c317.1771894643.5b5de64c https://errors.edgesuite.net/18.6824c317.1771894643.5b5de64c Source link

Access Denied

Access Denied You don’t have permission to access “http://www.ndtvprofit.com/personal-finance/review-your-salary-slip-before-the-new-income-tax-rules-come-into-effect-in-april-heres-why-10993265” on this server. Reference #18.cf9419b8.1770891916.182932de https://errors.edgesuite.net/18.cf9419b8.1770891916.182932de Source link